The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease. The imbalance of Th17/Treg cells has been reported in PBC patients. Low-dose IL-2 can alleviate disease severity through modulating CD4 + T cell subsets in patients with autoimmune diseases. Hence, the present study aimed to e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC gastroenterology 2024-02, Vol.24 (1), p.87-87, Article 87
Hauptverfasser: Wang, Zilong, Liu, Zhicheng, Zheng, Jiarui, Huang, Linxiang, Jin, Rui, Wang, Xiaoxiao, Chen, Dongbo, Xie, Yandi, Feng, Bo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease. The imbalance of Th17/Treg cells has been reported in PBC patients. Low-dose IL-2 can alleviate disease severity through modulating CD4 + T cell subsets in patients with autoimmune diseases. Hence, the present study aimed to examine the effects and mechanism of low-dose IL-2 in PBC mouse models. PBC models were induced in female C57BL/6 mice by two immunizations with 2OA-BSA at two-week intervals, and poly I: C every three days. PBC mouse models were divided into the IL-2 treated and untreated groups and low-dose IL-2 was injected at three different time points. Th17 and Tregs were analyzed by flow cytometry, and the related cytokines were analyzed by ELISA. Liver histopathology was examined by H&E and immunohistochemical staining. Twelve weeks after modeling, the serum AMA was positive and the ALP was significantly increased in PBC mouse models (P
ISSN:1471-230X
1471-230X
DOI:10.1186/s12876-024-03176-0